VFA
KRTX
Values First Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,039
| Closed | -$1.28M | – | 179 |
|
|
2023
Q4 | $1.28M | Sell |
4,039
-68
| -2% | -$21.5K | 0.77% | 42 |
|
|
2023
Q3 | $694K | Sell |
4,107
-83
| -2% | -$14K | 0.45% | 68 |
|
|
2023
Q2 | $909K | Sell |
4,190
-102
| -2% | -$22.1K | 0.55% | 52 |
|
|
2023
Q1 | $780K | Buy |
4,292
+286
| +7% | +$51.9K | 0.5% | 59 |
|
|
2022
Q4 | $787K | Sell |
4,006
-1,245
| -24% | -$245K | 0.55% | 54 |
|
|
2022
Q3 | $1.18M | Sell |
5,251
-496
| -9% | -$112K | 0.85% | 39 |
|
|
2022
Q2 | $727K | Sell |
5,747
-416
| -7% | -$52.6K | 0.52% | 60 |
|
|
2022
Q1 | $781K | Sell |
6,163
-237
| -4% | -$30K | 0.49% | 62 |
|
|
2021
Q4 | $838K | Sell |
6,400
-391
| -6% | -$51.2K | 0.5% | 68 |
|
|
2021
Q3 | $831K | Buy |
6,791
+365
| +6% | +$44.7K | 0.54% | 61 |
|
|
2021
Q2 | $732K | Buy |
6,426
+4,744
| +282% | +$540K | 0.5% | 72 |
|
|
2021
Q1 | $202K | Buy |
+1,682
| New | +$202K | 0.15% | 134 |
|